Association of depression with severe non-alcoholic fatty liver disease: evidence from the UK Biobank study and Mendelian randomization analysis Xiaorui Zhou Juan Liao Lu Long Scientific Reports (2024) Omega-3 fatty acids and major depression: a Mendelian randomization study R. Carnegie M. C. ...
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589-600. doi:10.1016/j.jhep.2016.05.013PubMedGoogle ScholarCrossref 6. Dyson J, Jaques B, Chattopadyhay D, et al. Hepatocellular cancer: the impact of obesity, type 2...
Non-alcoholic fatty liver disease (NAFLD) is usually a silent disease that occurs in a very high proportion of people with features of the metabolic syndrome, including overweight, insulin resistance and type 2 diabetes. Because obesity and type 2 diabetes are now extremely common in Westernised ...
Study participants in the included cohorts (a) were >18 years old, (b) had no major medical diagnoses (prior myocardial infarction, prior stroke, severe active cancer, severe renal disease, severe liver, or lung disease), (c) were not taking supplemental fish oil, and (d) did not die w...
NHS Choices. Non-alcoholic fatty liver disease (NAFLD). http://www.nhs.uk/conditions/fatty-liver-disease/Pages/Introduction.aspx Accessed 23 Feb 2017. https://en.wikipedia.org/wiki/Ballooning_degenerationandhttp://www.medilexicon.com/dictionary/23283 ...
Keywords: nonalcoholic fatty liver disease—NAFLD; lifestyle intervention; weight loss; diet; exercise 1. Introduction Non-alcoholic fatty liver disease (NAFLD) is a significant global health concern that has been increasing at an alarming rate. NAFLD encompasses a wide spectrum of clinical disease ...
For example, MCFA are absorbed from the gastrointestinal tract more efficiently than LCFA, and are transported via the portal vein directly to the liver for rapid oxidation, while LCFA are packaged into chylomicrons and travel through the lymphatic system, allowing for greater uptake by adipose ...